(1->4)-beta-D-glucan multiple interactions ISO RGD:736432 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of WNT2 mRNA CTD PMID:36331819 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of WNT2 mRNA CTD PMID:21983209 1-nitropyrene increases expression ISO RGD:736431 6480464 1-nitropyrene results in increased expression of WNT2 mRNA CTD PMID:21540303 17beta-estradiol increases expression ISO RGD:736431 6480464 Estradiol results in increased expression of WNT2 mRNA CTD PMID:15072547 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:736432 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of WNT2 mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to WNT2 promoter] CTD PMID:16214954 , PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736431 6480464 Tetrachlorodibenzodioxin results in decreased expression of WNT2 mRNA CTD PMID:36370075 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736432 6480464 Tetrachlorodibenzodioxin affects the expression of WNT2 mRNA CTD PMID:26377647 , PMID:36222588 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736432 6480464 Tetrachlorodibenzodioxin results in increased expression of WNT2 mRNA CTD PMID:18172886 , PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of WNT2 mRNA CTD PMID:23238561 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736432 6480464 Tetrachlorodibenzodioxin results in decreased expression of WNT2 mRNA CTD PMID:23238561 4,4'-diaminodiphenylmethane decreases expression ISO RGD:736432 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of WNT2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:736432 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of WNT2 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol decreases methylation ISO RGD:736432 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of WNT2 exon CTD PMID:33297965 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of WNT2 mRNA CTD PMID:21346803 5-aza-2'-deoxycytidine multiple interactions ISO RGD:736431 6480464 Decitabine inhibits the reaction [bisphenol A results in increased methylation of WNT2 promoter] CTD PMID:30303745 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of WNT2 mRNA CTD PMID:24780913 afimoxifene increases expression ISO RGD:736431 6480464 afimoxifene results in increased expression of WNT2 mRNA CTD PMID:15072547 all-trans-retinoic acid decreases expression ISO RGD:736431 6480464 Tretinoin results in decreased expression of WNT2 mRNA CTD PMID:17045167 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of WNT2 mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:736431 6480464 Antirheumatic Agents results in increased expression of WNT2 mRNA CTD PMID:24449571 arsenite(3-) increases expression ISO RGD:736432 6480464 arsenite results in increased expression of WNT2 mRNA CTD PMID:33053406 arsenite(3-) increases methylation ISO RGD:736431 6480464 arsenite results in increased methylation of WNT2 promoter CTD PMID:23974009 benzo[a]pyrene multiple interactions ISO RGD:736432 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to WNT2 promoter] CTD PMID:19654925 benzo[a]pyrene affects methylation ISO RGD:736431 6480464 Benzo(a)pyrene affects the methylation of WNT2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:736432 6480464 Benzo(a)pyrene results in increased expression of WNT2 mRNA CTD PMID:22228805 , PMID:32417428 benzo[a]pyrene increases mutagenesis ISO RGD:736431 6480464 Benzo(a)pyrene results in increased mutagenesis of WNT2 gene CTD PMID:25435355 bisphenol A increases expression ISO RGD:736432 6480464 bisphenol A results in increased expression of WNT2 mRNA CTD PMID:24465770 more ... bisphenol A increases methylation ISO RGD:736431 6480464 bisphenol A results in increased methylation of WNT2 promoter CTD PMID:30303745 bisphenol A decreases expression ISO RGD:736431 6480464 bisphenol A results in decreased expression of WNT2 protein CTD PMID:30303745 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of WNT2 mRNA CTD PMID:30816183 , PMID:31129395 bisphenol A multiple interactions ISO RGD:736431 6480464 Decitabine inhibits the reaction [bisphenol A results in increased methylation of WNT2 promoter] CTD PMID:30303745 bisphenol A decreases expression ISO RGD:736432 6480464 bisphenol A results in decreased expression of WNT2 mRNA, bisphenol A results in decreased expression of WNT2 protein CTD PMID:30303745 bisphenol A increases methylation ISO RGD:736432 6480464 bisphenol A results in increased methylation of WNT2 promoter CTD PMID:30303745 bisphenol F increases expression ISO RGD:736432 6480464 bisphenol F results in increased expression of WNT2 mRNA CTD PMID:30951980 cadmium dichloride multiple interactions ISO RGD:736431 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of WNT2 mRNA CTD PMID:12634122 carbon nanotube decreases expression ISO RGD:736432 6480464 Nanotubes more ... CTD PMID:25554681 chloroprene decreases expression ISO RGD:736432 6480464 Chloroprene results in decreased expression of WNT2 mRNA CTD PMID:23125180 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of WNT2 mRNA CTD PMID:23125180 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of WNT2 mRNA CTD PMID:18502319 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of WNT2 mRNA CTD PMID:27899881 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of WNT2 mRNA CTD PMID:26577399 deguelin increases expression ISO RGD:736431 6480464 deguelin results in increased expression of WNT2 mRNA CTD PMID:19861542 dextran sulfate multiple interactions ISO RGD:736432 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of WNT2 mRNA CTD PMID:29950665 diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of WNT2 mRNA CTD PMID:18502319 dichromium trioxide multiple interactions ISO RGD:736431 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of WNT2 mRNA CTD PMID:12634122 dieldrin decreases expression EXP 6480464 Dieldrin results in decreased expression of WNT2 mRNA CTD PMID:19130878 dioxygen multiple interactions ISO RGD:736431 6480464 CA9 mutant form inhibits the reaction [[Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of WNT2 mRNA] CTD PMID:26305601 dioxygen multiple interactions ISO RGD:736432 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of WNT2 mRNA CTD PMID:30529165 dioxygen increases expression ISO RGD:736431 6480464 [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of WNT2 mRNA CTD PMID:26305601 dorsomorphin multiple interactions ISO RGD:736431 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:736431 6480464 Doxorubicin results in decreased expression of WNT2 mRNA CTD PMID:29803840 entinostat increases expression ISO RGD:736431 6480464 entinostat results in increased expression of WNT2 mRNA CTD PMID:27188386 ethanol increases expression ISO RGD:736431 6480464 Ethanol results in increased expression of WNT2 mRNA CTD PMID:31059573 finasteride affects expression EXP 6480464 Finasteride affects the expression of WNT2 mRNA CTD PMID:30768126 fulvestrant decreases expression ISO RGD:736431 6480464 fulvestrant results in decreased expression of WNT2 mRNA CTD PMID:15072547 lead diacetate multiple interactions ISO RGD:736431 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of WNT2 mRNA CTD PMID:12634122 lipopolysaccharide multiple interactions ISO RGD:736431 6480464 [S-(1 more ... CTD PMID:35811015 N(gamma)-nitro-L-arginine methyl ester multiple interactions ISO RGD:736432 6480464 ALKBH5 protein promotes the reaction [NG-Nitroarginine Methyl Ester results in decreased expression of WNT2 protein] CTD PMID:34995009 N(gamma)-nitro-L-arginine methyl ester decreases expression ISO RGD:736432 6480464 NG-Nitroarginine Methyl Ester results in decreased expression of WNT2 protein CTD PMID:34995009 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of WNT2 mRNA CTD PMID:28801915 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO RGD:736431 6480464 Methylnitronitrosoguanidine results in increased expression of WNT2 mRNA CTD PMID:12634122 N-nitrosodiethylamine decreases expression ISO RGD:736432 6480464 Diethylnitrosamine results in decreased expression of WNT2 mRNA CTD PMID:24535843 nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of WNT2 mRNA CTD PMID:19130878 nickel subsulfide decreases expression EXP 6480464 nickel subsulfide results in decreased expression of WNT2 mRNA CTD PMID:24952340 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of WNT2 mRNA CTD PMID:17270562 , PMID:18280291 nitrofen decreases expression ISO RGD:736432 6480464 nitrofen results in decreased expression of WNT2 mRNA CTD PMID:21034933 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of WNT2 mRNA, [Topotecan co-treated with oxaliplatin] results in decreased expression of WNT2 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of WNT2 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:736432 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of WNT2 mRNA CTD PMID:34911549 paracetamol affects expression ISO RGD:736432 6480464 Acetaminophen affects the expression of WNT2 mRNA CTD PMID:17562736 paraquat increases expression EXP 6480464 Paraquat results in increased expression of WNT2 mRNA CTD PMID:32680482 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:736432 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of WNT2 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of WNT2 mRNA CTD PMID:36331819 phenobarbital affects expression ISO RGD:736432 6480464 Phenobarbital affects the expression of WNT2 mRNA CTD PMID:23091169 resveratrol decreases expression ISO RGD:736431 6480464 resveratrol results in decreased expression of WNT2 mRNA, resveratrol results in decreased expression of WNT2 protein CTD PMID:25061499 , PMID:25896424 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:736431 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of WNT2 mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:736431 6480464 [S-(1 more ... CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:736431 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT2 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:736431 6480464 Silicon Dioxide results in increased expression of WNT2 mRNA CTD PMID:21540303 sodium arsenite multiple interactions ISO RGD:736431 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of WNT2 mRNA CTD PMID:12634122 titanium dioxide multiple interactions ISO RGD:736432 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of WNT2 mRNA CTD PMID:29950665 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of WNT2 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of WNT2 mRNA, [Topotecan co-treated with oxaliplatin] results in decreased expression of WNT2 mRNA CTD PMID:25729387 triclosan decreases expression ISO RGD:736431 6480464 Triclosan results in decreased expression of WNT2 mRNA CTD PMID:30510588 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of WNT2 mRNA CTD PMID:30589522 valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of WNT2 promoter CTD PMID:20734317 valproic acid multiple interactions ISO RGD:736431 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT2 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:736431 6480464 Valproic Acid results in increased expression of WNT2 mRNA CTD PMID:23179753 more ... valproic acid decreases methylation ISO RGD:736431 6480464 Valproic Acid results in decreased methylation of WNT2 gene CTD PMID:29154799 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of WNT2 mRNA, Valproic Acid results in increased expression of WNT2 protein CTD PMID:20734317
